Skip to content
★ Sign in to follow
RA

Richard A. Zordani Jr.

Board Director
Director
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
8
Company
1
▲ Purchases (8 ops.)
€47k
▼ Sales (0 ops.)
—

Latest filing published 26 Dec 2024 for Galectin Therapeutics INC, €7,846.

Filing timeline

BuySale
Richard A. Zordani Jr.

Insider track record

Disclosed buys
8
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-6.3%

Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Richard A. Zordani Jr.: trading record in brief

This profile gathers the share dealings of Richard A. Zordani Jr. in Galectin Therapeutics Inc, where the filings describe the role as board member. Over a trading history stretching from 14 January 2022 to 24 December 2024, the count stands at 8 filings.

The open-market record is one-sided, with 8 purchases worth €47k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2024 to date brings 5 purchases and no sales.

In size, the median ticket on the buying side is €5,475. 3 out of 8 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 26 December 2024: an open-market purchase of €7,846, in Galectin Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Richard A. Zordani Jr.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total

6 of 6 declarations